Genflow Biosciences Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	0.59	0.59	0.32	0.17	-	-
Revenue	0.59	0.59	0.32	0.17	-	-
Revenue Growth	82.73%	82.73%	88.67%	-	-	-
Gross Profit	0.59	0.59	0.32	0.17	-	-
Selling, General & Admin	0.36	0.89	0.76	0.84	1.82	1.02
Research & Development	1.11	1.11	1.15	1.19	-	-
Other Operating Expenses	0.21	-	-	-	-0.49	0.05
Operating Expenses	1.69	2	1.91	2.03	1.33	1.08
Operating Income	-1.1	-1.42	-1.59	-1.86	-1.33	-1.08
Interest Expense	-0	-	-	-	-0	-0
Pretax Income	-1.1	-1.42	-1.59	-1.86	-1.34	-1.08
Net Income	-1.1	-1.42	-1.59	-1.86	-1.34	-1.08
Net Income to Common	-1.1	-1.42	-1.59	-1.86	-1.34	-1.08
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	497	427	334	293	293	167
Shares Outstanding (Diluted)	497	427	334	293	293	167
Shares Change	35.17%	27.58%	14.34%	-	75.50%	20835.62%
EPS (Basic)	-0.00	-0.00	-0.00	-0.01	-0.00	-0.01
EPS (Diluted)	-0.00	-0.00	-0.00	-0.01	-0.00	-0.01
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-1.23	-1.44	-1.08	-1.66	-1.37	-0.82
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.01	-0.01	-0.01
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-187.78%	-242.07%	-495.28%	-1095.26%	-	-
Profit Margin	-187.87%	-242.07%	-495.28%	-1095.26%	-	-
Free Cash Flow Margin	-210.79%	-245.32%	-337.71%	-979.26%	-	-
EBITDA	-1.1	-1.42	-1.59	-1.86	-1.33	-
EBITDA Margin	-187.65%	-241.88%	-	-	-	-
D&A For EBITDA	0	0	0	0	0	-
EBIT	-1.1	-1.42	-1.59	-1.86	-1.33	-1.08
EBIT Margin	-187.78%	-242.07%	-	-	-	-
Revenue as Reported	0.59	0.59	0.32	0.17	-	-